CR20150065A - HUMAN R-SPONDIN PROTEIN UNION AGENTS (RSPO3) AND USES OF THE SAME - Google Patents

HUMAN R-SPONDIN PROTEIN UNION AGENTS (RSPO3) AND USES OF THE SAME

Info

Publication number
CR20150065A
CR20150065A CR20150065A CR20150065A CR20150065A CR 20150065 A CR20150065 A CR 20150065A CR 20150065 A CR20150065 A CR 20150065A CR 20150065 A CR20150065 A CR 20150065A CR 20150065 A CR20150065 A CR 20150065A
Authority
CR
Costa Rica
Prior art keywords
rspo3
human
same
agents
spondin protein
Prior art date
Application number
CR20150065A
Other languages
Spanish (es)
Inventor
Austin L Gurney
Christopher J Bond
Original Assignee
Oncomed Pharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US2013/050300 external-priority patent/WO2014012007A2/en
Application filed by Oncomed Pharm Inc filed Critical Oncomed Pharm Inc
Publication of CR20150065A publication Critical patent/CR20150065A/en

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

La presente invención se relaciona con agentes de unión de RSPO, particularmente agentes de unión de RSPO y métodos de uso de agentes para tratar enfermedades tales como cáncer.The present invention relates to RSPO binding agents, particularly RSPO binding agents and methods of using agents to treat diseases such as cancer.

CR20150065A 2012-07-13 2015-02-09 HUMAN R-SPONDIN PROTEIN UNION AGENTS (RSPO3) AND USES OF THE SAME CR20150065A (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201261671421P 2012-07-13 2012-07-13
US201361753184P 2013-01-16 2013-01-16
US201361789156P 2013-03-15 2013-03-15
PCT/US2013/050300 WO2014012007A2 (en) 2012-07-13 2013-07-12 Rspo3 binding agents and uses thereof

Publications (1)

Publication Number Publication Date
CR20150065A true CR20150065A (en) 2015-03-13

Family

ID=53801268

Family Applications (1)

Application Number Title Priority Date Filing Date
CR20150065A CR20150065A (en) 2012-07-13 2015-02-09 HUMAN R-SPONDIN PROTEIN UNION AGENTS (RSPO3) AND USES OF THE SAME

Country Status (1)

Country Link
CR (1) CR20150065A (en)

Similar Documents

Publication Publication Date Title
PE20150360A1 (en) HUMAN R-SPONDINE PROTEIN BINDING AGENTS (RSP03) AND USES OF THEM
PH12016501139A1 (en) Bicyclic heterocycle compounds and their uses in therapy
MX2019013670A (en) Antibody and protein formulations.
UY34876A (en) ANTI-EGFR ANTIBODIES AND USES OF THE SAME
MX391051B (en) ANTI-CD47 ANTIBODIES AND THEIR USES.
CL2015002501A1 (en) Compounds and uses of these for hemoglobin modulation
MX2016004340A (en) HETEROCICLICAL COMPOUNDS AND USES OF THE SAME.
EA201590987A1 (en) CONNECTIONS AND METHODS OF THEIR APPLICATION
EA201270722A1 (en) RIFAXIMINE FORMS AND THEIR APPLICATION
CL2014001853A1 (en) Compounds derived from substituted pyrrole; preparation procedure; pharmaceutical composition that contains them; pharmaceutical combination; use to treat diseases such as cancers and immune system diseases.
UY35427A (en) COMPOUNDS AND THEIR USES IN THE MODULATION OF HEMOGLOBIN
MX2015015009A (en) Oral dosing of glp-1 compounds.
CL2015002567A1 (en) Compounds and their uses to modulate hemoglobin
AR089993A1 (en) PEPTIDOMIMETIC MACROCICLES
UY35425A (en) COMPOUNDS AND THEIR USES IN THE MODULATION OF HEMOGLOBIN
NI201300041A (en) SPIRO-OXINDOL MDM2 ANTAGONISTS
EA201500314A1 (en) DOSAGE FORMS OF ENZALUTAMIDE
MX2017013142A (en) COMBINED THERAPY TO TREAT CANCER.
MX373187B (en) COMBINATION THERAPY TO TREAT CANCER.
UY34680A (en) ANTI-CD27 HUMAN ANTIBODIES, METHODS, AND USES
MX392752B (en) COMBINATION THERAPY TO TREAT CANCER.
GB201209613D0 (en) New compounds
WO2015009726A3 (en) Medical uses of cd38 agonists
MX366804B (en) R-spondin translocations and methods using the same.
MY188139A (en) Sodium channel modulators for the treatment of pain